Angiodynamics ANGO Cash Flow Statement (2010-2026)

NASDAQ ANGO
$11.89 +0.08 (+0.68%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Angiodynamics Quarterly Cash Flow Statement

Periods 65 quarters
Latest Aug 2026

Angiodynamics reported cash from operations of -$15.33M and free cash flow of -$18.48M for the quarter ended Aug 2026, up 3.7% year over year. This cash flow statement covers 65 quarters of results from Aug 2010 through Aug 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Aug2010 Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025 Feb2026 May2026 Aug2026
Operating Activities
Net Income
-8.35M-4.96M-13.00M-13.00M-8.49M-9.49M-21.47M45.88M-29.05M-187.74M-13.45M-12.80M-10.74M-4.41M-6.05M-10.90M-6.35M-8.08M-11.41M-7.10M
Depreciation and DepletionDep. & Depletion
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
7.28M7.41M7.67M7.66M7.82M7.84M7.56M6.69M6.69M7.52M6.82M6.79M6.86M6.32M5.83M5.95M5.82M5.59M5.60M5.50M
Share-based CompensationStock Comp.
3.01M2.35M2.90M3.02M3.35M1.80M2.98M4.14M1.88M2.61M1.90M3.21M2.53M2.40M1.64M4.47M2.89M2.68M3.92M4.50M
Deferred Taxes
-0.57M-0.86M-0.59M-0.91M-0.62M-0.23M-0.56M-11.42M16.37M-12.09M-0.83M-0.34M-0.25M-0.21M-0.19M-0.02M-0.05M0.06M0.15M-0.31M
Cash from Discontinued OperationsCash from Discont. Ops
Gains from Sales and DivestituresGains Divest
47.84M6.66M
Asset Writedowns and ImpairmentWritedown
0.07M0.15M0.15M0.09M0.06M14.41M0.87M158.61M0.02M0.04M0.04M0.08M-0.03M0.31M0.04M0.99M0.08M
Other non-cash itemsOther Non-Cash
0.61M0.20M-1.48M0.78M1.65M0.23M-3.86M0.26M0.22M0.11M-0.05M0.96M0.16M0.04M0.23M0.89M1.70M-0.33M
Change in Working Capital
Change in ReceivablesChange Receivables
2.89M3.52M10.71M1.43M-0.41M-1.78M2.06M-3.16M2.48M-1.67M-5.55M-3.78M3.73M0.47M-0.45M-0.14M1.57M1.42M2.90M-3.47M
Change in InventoryChange Inventory
-1.15M-0.11M3.38M6.24M5.59M0.42M-4.06M4.57M4.27M-2.02M2.59M4.05M1.25M-2.81M-1.15M0.19M3.28M-7.06M-6.46M2.72M
Change in Accured ExpensesChange Accured Exp.
1.83M-7.29M15.71M-8.99M6.15M-4.27M9.25M-16.54M15.57M17.71M10.79M-14.98M7.48M-10.96M2.59M-10.70M3.18M-6.01M7.70M-17.42M
Change in Other Operating AssetsOther Assets Change
0.83M2.96M-2.14M5.73M-1.80M-3.54M-0.72M4.17M0.81M2.59M4.03M0.84M-0.76M9.39M-12.55M5.53M-3.23M4.08M-5.25M1.02M
Other Working Capital ChangesOther WC Changes
-0.83M-2.96M2.14M-5.73M1.80M3.54M0.72M-4.17M-0.81M-2.59M-4.03M-0.84M0.76M-9.39M12.55M-5.53M3.23M-4.08M5.25M-1.02M
Cash from OperationsCash from Ops.
1.94M-8.79M8.56M-24.75M7.50M1.37M15.95M-25.90M5.27M-12.53M5.00M-18.25M2.47M-13.16M18.81M-15.91M4.66M-3.11M17.45M-15.33M
Investing Activities
Capital ExpendituresCapex
3.85M2.59M-7.64M3.04M2.50M2.15M-3.87M1.56M1.79M1.85M-2.68M2.41M1.96M3.19M-3.09M1.55M1.62M1.51M-2.10M3.15M
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in Property, Plant and EquipmentChange in PP&E
-3.85M-2.59M7.64M-3.04M-2.50M-2.15M3.87M-1.56M-1.79M-1.85M2.68M-2.41M-1.96M-3.19M3.09M-1.55M-1.62M-1.51M2.10M-3.15M
Change in IntangiblesChange Intangibless
0.54M
Acquisitions
0.54M3.25M
Divestments
100.00M34.50M
Net of Acquisitions & DivestmentsNet Acquisitions
-0.54M100.00M31.25M
Purchase of InvestmentsInvestments Purchased
Sale and Maturity of InvestmentsInvestments Sold
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
-3.85M-2.59M-3.77M-3.58M-2.50M-2.15M-1.53M98.44M-1.79M29.40M-2.34M-2.41M-1.96M-3.19M-2.62M-1.55M-1.62M-1.51M-1.27M-3.15M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
70.00M
Long-Term Debt RepaymentsLT Debt Repayment
45.00M50.00M0.06M0.09M0.09M0.09M0.10M0.10M0.10M
Non-Current Debt
25.00M-50.00M-0.06M-0.09M-0.09M-0.09M-0.10M-0.10M-0.10M
Net Debt Issuances and RepaymentsNet Debt Issuance
25.00M-50.00M-0.06M-0.09M-0.09M-0.09M-0.10M-0.10M-0.10M
Change in Capital Stock
Common Stock IssuedStock Issued
0.08M0.15M0.94M0.41M-0.35M0.69M0.04M-0.01M0.90M0.23M0.72M-0.01M-1.28M
Shares Repurchased
0.55M1.12M
Net Shares Issued and RepurchasedNet Shares Issued
0.08M0.15M0.94M0.41M-0.35M0.69M-0.51M-1.12M0.90M0.23M0.72M-0.01M-1.28M
Net Equity Issued and RepurchasedNet Equity Issued
0.08M0.15M0.94M0.41M-0.35M0.69M-0.51M-1.12M0.90M0.23M0.72M-0.01M-1.28M
Other financing activitiesOther financing
-0.71M-0.05M-10.00M-5.00M-5.68M
Cash from Financing ActivitiesCash from Financing
0.94M0.97M0.33M24.38M0.10M0.94M-59.59M-0.35M0.69M-5.00M-0.51M-1.12M7.15M-5.77M0.14M-0.09M0.62M-0.11M-1.38M
Additional items
Exchange Rate EffectFX Effect
-0.22M0.02M-0.18M-0.32M0.19M0.09M0.08M0.01M0.19M-0.02M-0.06M0.12M-0.31M-0.13M0.72M0.19M-0.07M0.17M-0.02M-0.04M
Change in Cash
-1.18M-10.40M4.94M-4.26M5.29M0.25M14.51M12.97M3.31M17.56M-2.40M-21.05M-0.92M-9.33M11.13M-17.13M2.88M-3.83M16.05M-19.89M
Ending Cash Balance
34.29M23.89M28.83M24.56M29.86M30.11M44.62M57.59M60.90M78.45M76.06M55.01M54.09M44.76M55.89M38.76M41.64M37.81M53.86M33.97M
Free Cash FlowFCF
-1.91M-11.38M16.20M-27.78M5.00M-0.78M19.82M-27.46M3.47M-14.37M7.68M-20.66M0.51M-16.35M21.90M-17.47M3.04M-4.62M19.55M-18.48M
Net Cash FlowNCF
-0.97M-10.42M5.12M-3.95M5.11M0.17M14.43M12.95M3.12M17.57M-2.34M-21.17M-0.61M-9.20M10.42M-17.32M2.95M-4.00M16.07M-19.85M

Angiodynamics Cash Flow Statement API

Pull Angiodynamics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ANGO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY